Catalyst Wire Dossier Catalyst Wire Dossier

TDV (tetravalent dengue vaccine candidate)

tetravalent dengue vaccine · Takeda
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TDV (tetravalent dengue vaccine candidate), covering 2016-06-29 to 2024-04-10. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Safety of Tetravalent Dengue Vaccine Candidate (TDV) in Flavivirus-Naïve and Dengue-Immune Adults [Phase 2]

See pricing